Vontobel Financial Products GmbH (F30728) Noticias

Thanks for the reminder DJ, it pretty much lays out a lot of what we'll see in the future.

One question that really I feel uncertain about is the ability to make the improvements in DCVax-L and put it immediately into a Phase 3 trial.

In other companies when changes wer

4-2-21. Can it be possible to be more wrong?????





https://investorshub.advfn.com/uimage/uploads/2025/1/31/qutyxIMG_6318.jpeg







.

Im in this at .0001. Double or nothing.

A formal application to rename BNCM to DELEX and update the ticker symbol will be applied from Q1 2025, aligning with the new direction of the merged company. This rebrand reflects the company’s ambition to further solidify its presence in the global healthcare market and prepare for an exciting pha

This stock is so last year. Good luck. For me the party is over.

Oh yes shorty was wrong, thanks in advance! https://investorshub.advfn.com/uimage/uploads/2016/1/26/hubmx4.gif

Right I lost the bet yesterday and would be happier when we will see 3,4,5 bucks...

Material news February can do some magic 

LOLOLOLOL...where I live, in a rural area of Vegas (on the outskirts), exit right before Mt. Charleston (Lee Canyon), there's Raven's.

Probably one of the most intelligent birds.They resemble a crow, only much larger. I can 100% confirm that they LOVE trash....as I witnessed them pic

BITCOIN 🥴📉🖌️📈🖍️😵‍💫📱 Cross Eyed Mary $140,000 no chart needed

"Bite me." See, where this goes is - No you bite me..."#$@." So that's as helpful as the other BS. So obviously, a few people are here are NOT here to help, they're just here to BS themselves. Oh, and they're banding together: so it's here are some documents which I believe firmly are assuring us of

BITCOIN BCH $140,000 FEBRUARY TARGET Pink Floyd - MONEY

UNCY is supposed to have a commercialization plan presented this Qt .
The Co needs to ramp up but and be ready to roll as soon as OLC is approved . The time line for the TDAPA process ...which is CMS payments beginning is at best 3 mths from approval .
Some recent examples
For

🥄,could be spoon bending time...go... $AABB

And you naysayers...never mind you....don't need you!

How to Bend a Spoon with Your Mind
YouTube·Skeptic·Jan 5, 2009

I'm having a few drinks tonight listening to the devils violinist, I am retired thanks to plays like $PSRU!

https://www.youtube.com/watch?v=vihq22xpl1A

$60.00 as of the last filing...

I don't know. You're the f@cking expert. You've devoted your entire pathetic life to this shit.

I'm not even trying to be funny when I say this but the other day I saw a crow eating garbage in a parking lot and I literally thought of you.

RDAR

XRP ETF no more lawsuit ✊😎☝️ WOOHOOOOOO next level up 🪙🪙Hotel California

Meaningless since a true supply/demand dynamic isn't operating.

The real upside lies in RSV and Enanta’s shift toward becoming an immunology-focused company. Mavyret remains a factor, but the real potential comes from these strategic moves. If executed well, this could be a great setup—we’ll see how it unfolds in the next few quarters.

The waiting

I’m not sure why, but I can’t believe you are still a believer. Now, more than ever, you have to admit I was right all along. Or couldn’t you care less?

Since our patience is starting to grow weary, I figured I would remind everyone of the last 10Q's highlights and what's in store here soon:

Overview

During the first nine months of 2024, the Company continued its progress on multiple fronts, including the following.

$13 volume

CRISPR platforms can result in off-target modifications, unwanted on-target modifications, and genomic rearrangements.

Kim switched to a non-crispr knock in/knock out method. The knock-in knock-out technology allows KBL to work with more complex protein sequences, which are about four